phase 2_results
saveCity of Hope — Methotrexate Teva (Phase II Trial Results)
community read0 votes
Therapy area: Oncology. Indication: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Myelodysplastic Syndrome (Preleukemia)
Data sources
globaldata
Found something off?
drug timeline · 7
- phase 1 2 completionHenan Cancer Hospital — methotrexate (Phase I/II Trial Completion)Apr 30, 2026 · 160d ago
- approvalMETHOTREXATE SODIUM — FDA approvalApr 15, 2026 · 175d ago
- approvalMETHOTREXATE — FDA approvalMar 13, 2026 · 208d ago
- approvalMETHOTREXATE — FDA approvalMay 29, 2025 · 496d ago
- approvalMETHOTREXATE — FDA approvalSep 12, 2024 · 755d ago
- approvalMETHOTREXATE — FDA approvalMar 10, 2022 · 1672d ago
- approvalMETHOTREXATE — FDA approvalAug 24, 2020 · 2235d ago
same company · ±60 days · 5
- phase 1 initiationCHOP [cyclophosphamide + doxorubicin + vincristine + prednisolone]: City of Hope — CHOP [cyclophosphamide + doxorubicin + vincristine + prednisolone] (Phase I Trial Initiation)Apr 27, 2026
- grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Role and regulation of methylarginine effector TDRD3 in T cell immunityApr 8, 2026
- grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — A novel pentavalent circular RNA-based EBV vaccineApr 1, 2026
- grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — An exosome-based liquid biopsy assay for the non-invasive early detection of ...Mar 16, 2026
- grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — The Novel Role and Mechanism of RBM33 in LeukemogenesisMar 1, 2026
related news · 3
🐶 often sniffed alongside
top 8- tagApproval40 co-mentions · 13 sources
- drugMethotrexate Teva39 co-mentions · 18 sources
- drugMethotrexate Intas39 co-mentions · 18 sources
- drugMETHOTREXATE39 co-mentions · 18 sources
- drugMETHOTREXATE SODIUM32 co-mentions · 11 sources
- tagOncology4 co-mentions · 2 sources
- tagDrug Shortage3 co-mentions · 3 sources
- tagAML1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that